Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 18/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 17/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 12/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14224580 | 0.84 | SLC6A4 (0.48) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 | |
| SCHEMBL14222789 | 0.84 | SLC6A4 (0.48) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 | |
| SCHEMBL14224510 | 0.84 | SLC6A4 (0.48) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 | |
| SCHEMBL20066135 | 0.81 | SLC6A4 (0.51) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 | |
| SCHEMBL181909 | 0.79 | SLC6A4 (0.42) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 | |
| SCHEMBL1033810 | 0.79 | SLC6A4 (0.42) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 | |
| SCHEMBL65492 | 0.79 | SLC6A4 (0.42) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 | |
| Hydrochloric Acid SCHEMBL25408690 | 0.78 | SLC6A4 (0.41) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 | |
| Ammonia Solution, Strong SCHEMBL19410295 | 0.78 | SLC6A4 (0.41) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 | |
| Hydrochloric Acid SCHEMBL31485474 | 0.78 | SLC6A4 (0.41) | SLC6A4SLC6A2KCNH2SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130172313-A1 | Carbapenem Antibacterials with Gram-Negative Activity | FOB SYNTHESIS, INC. (US) | 2013-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172313-A1 | Carbapenem Antibacterials with Gram-Negative Activity | MGAM, GSK3B, GSK3A | SLC6A4 3682/4885SLC6A2 2589/4885KCNH2 1105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.